For example, the presence of a PTEN mutation, especially when mutated concurrently with a PIK3CA and KRAS mutation, may predict sporadic MMR deficient endometrial cancer; the wild-type status of PTEN may be associated with LS-associated endometrial cancer [30,31]. This evidence concerns the gene PTEN and endometrial cancer.